Noureddin M, Vipani A, Bresee C, et al
Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M: Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptordependent andindependent pathways
However, the mechanism of this dual effect of 2DG remains unknown (264)
[18] 73m) All agents require caution if significant dehydration occurs due to gastrointestinal side effects Ongoing Monitoring Regular follow-up should include: Glycaemic control : HbA1c monitoring every 36 months to assess diabetes management
The "Start Low, Go Slow" Approach When increasing your fiber intake while on GLP-1 medications: Begin gradually : Adding too much fiber too quickly can cause bloating, gas, and discomfortespecially when your digestive system is already adjusting to medication
16, 560 (2015) InChi InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1 Major tripeptide widely distributed in both plants and animals